South Korea's former defense minister tried to commit suicide in prison. The Korean Ministry of Justice disclosed details. According to Yonhap News Agency's report on the 11th, South Korea's former defense minister Jin Longxian attempted suicide in prison on the evening of 10th. In response, Shen Ronghai, head of the Department of Corrections of the Korean Ministry of Justice, said that at present, Jin Longxian "has no abnormal physical condition." According to the report, Shen Ronghai said on the 11th that at around 11: 52 last night (10th), before the arrest warrant was issued, the staff found him trying to connect clothes into a rope in the bathroom in an attempt to commit suicide. Shen Ronghai added that the staff immediately took action and opened the door, and then Jin Longxian gave up suicide. At present, Jin Longxian has been placed in the protection room, and according to the report, his physical condition is not abnormal for the time being. (Yonhap News Agency)China Overseas Development: The annual interest of "23 Zhonghai 04" will be paid on December 12th. On December 10th, China Overseas Development (00688.HK) announced that China Overseas Enterprise Development Group Co., Ltd., a wholly-owned subsidiary of the company, will pay the annual interest of "23 Zhonghai 04" on December 12th, totaling 96 million yuan. The total amount of bonds issued in this issue is 3 billion yuan, and the issuance period is 5 years. The coupon rate of bonds in this issue is 3.20%.Former South Korean Defense Minister Jin Longxian attempted suicide in prison. (CCTV News)
A court in Hong Kong dismissed the liquidation case against Territorial Holdings, and a court in Hong Kong dismissed the liquidation case after the petition against Territorial Holdings, a real estate developer in China, was revoked. Our headquarters finance group withdrew the petition, and the debts and expenses have been settled. The liquidation petition was filed in September, involving an outstanding sum of HK$ 275,633.29. (Interface News)Tang Daizhi, the former deputy chief economist of China Offshore Oil Group Co., Ltd., was investigated. According to the news from the Discipline Inspection and Supervision Team of China Offshore Oil Group Co., Ltd. and the Supervision Committee of Jiangsu Provincial Commission for Discipline Inspection, Tang Daizhi, the former deputy chief economist of China Offshore Oil Group Co., Ltd., the general manager of human resources department and the head of party organization department, is suspected of serious violation of discipline and law, and is currently under disciplinary review and supervision investigation by the Discipline Inspection and Supervision Team of China Offshore Oil Group Co., Ltd. and the Jiangsu Provincial Supervision Committee.Starbucks China responded to the newly created position of Chief Growth Officer: to promote the sustainable development of Starbucks brand in China. Recently, some media reported that the management of Starbucks China continued to adjust and hired CGO to manage the growth from digital marketing companies. In response to the above information, Sina Technology verified Starbucks, and the official response said: China is Starbucks' largest international market and an important engine for the company's future growth. In November, Starbucks China established the Chief Growth Officer (CGO) organization and appointed Tony Yang as the company's Chief Growth Officer (CGO). The establishment of CGO organization will continue to strengthen Starbucks' coffee leadership, accelerate the product innovation with coffee as the core, better refresh customers' Starbucks experience at various contacts through integrated marketing strategies, and promote the sustainable development of Starbucks brand in China. At present, Starbucks has more than 7,600 stores in China, reaching a new development milestone covering 1,000 county-level markets. (Sina Technology)
The "moderately loose" monetary policy boosted the confidence of all parties. A50ETF Huabao (159596) attracted 17.02 million yuan of gold yesterday. On December 11, the Shanghai Composite Index fluctuated within a narrow range in the morning, and A50ETF Huabao (159596) fell slightly by 0.18% with a turnover of 84.21 million yuan. In terms of constituent stocks, the top ten awkward stocks are mixed. On the upside, Midea Group led the gains, followed by Zijin Mining and Changjiang Power. On the downside, Hengrui Pharma led the decline. In terms of capital flow, A50ETF Huabao (159596) received a net inflow of 17.02 million yuan yesterday. China Post Securities said that the the Political Bureau of the Communist Party of China (CPC) Central Committee meeting continued to actively set the tone, and the policy turned loose, and expanding domestic demand in all directions became the current policy direction. This meeting made it clear that "strengthening unconventional countercyclical adjustment" and the fiscal policy adjustment was "more active", which basically met market expectations; The monetary policy is set to be "moderately loose", and the tone is adjusted again after 14 years. Next year, it is expected to be wide in currency and credit.China Minerals and Guangxi Iron and Steel have established mining technology companies. The enterprise search APP shows that recently, China National Mining Chain (Guangxi) Mining Technology Co., Ltd. was established, with Ji Wendong as the legal representative and a registered capital of 90 million yuan. Its business scope includes mineral washing and processing, metal ore sales and metal material sales. Enterprise survey shows that the company is jointly owned by China Mineral's China Mineral Resources Group International Supply Chain Co., Ltd. and Guangxi Iron and Steel Group Co., Ltd.Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.